Fonte: Arthristis and rheumatism. Nome do evento: 2013 Annual meeting. Unidade: FM
Assuntos: POLISSACARÍDEOS BACTERIANOS, VACINAS, NECROSE, ARTERIOSCLEROSE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia E. et al. 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 13 nov. 2024. , 2013APA
Aikawa, N. E., França, I. L. A., Ribeiro, A. C. B., Sallum, A. M. S., Bonfá, E. S. D. de O., & Silva, C. A. A. da. (2013). 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo.NLM
Aikawa NE, França ILA, Ribeiro ACB, Sallum AMS, Bonfá ESD de O, Silva CAA da. 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. 2013 ; 65( S10): S923.[citado 2024 nov. 13 ]Vancouver
Aikawa NE, França ILA, Ribeiro ACB, Sallum AMS, Bonfá ESD de O, Silva CAA da. 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity. Arthristis and rheumatism. 2013 ; 65( S10): S923.[citado 2024 nov. 13 ]
